Follow
David Donald Scott
David Donald Scott
Verified email at email.arizona.edu
Title
Cited by
Cited by
Year
Structural insights into TDP-43 and effects of post-translational modifications
L François-Moutal, S Perez-Miller, DD Scott, VG Miranda, N Mollasalehi, ...
Frontiers in molecular neuroscience 12, 301, 2019
1042019
Small Molecule Targeting TDP-43’s RNA Recognition Motifs Reduces Locomotor Defects in a Drosophila Model of Amyotrophic Lateral Sclerosis (ALS)
L François-Moutal, R Felemban, DD Scott, MR Sayegh, VG Miranda, ...
ACS chemical biology 14 (9), 2006-2013, 2019
482019
The natural flavonoid naringenin elicits analgesia through inhibition of NaV1. 8 voltage-gated sodium channels
Y Zhou, S Cai, A Moutal, J Yu, K Gómez, CL Madura, Z Shan, NYN Pham, ...
ACS Chemical Neuroscience 10 (12), 4834-4846, 2019
232019
Selective targeting of NaV1. 7 via inhibition of the CRMP2-Ubc9 interaction reduces pain in rodents
S Cai, A Moutal, J Yu, LA Chew, J Isensee, R Chawla, K Gomez, S Luo, ...
Science Translational Medicine 13 (619), eabh1314, 2021
222021
An allosteric modulator of RNA binding targeting the N-terminal domain of TDP-43 yields neuroprotective properties
N Mollasalehi, L Francois-Moutal, DD Scott, JA Tello, H Williams, ...
ACS chemical biology 15 (11), 2854-2859, 2020
212020
Chemical shift perturbation mapping of the Ubc9-CRMP2 interface identifies a pocket in CRMP2 amenable for allosteric modulation of Nav1. 7 channels
L François-Moutal, DD Scott, S Perez-Miller, V Gokhale, M Khanna, ...
Channels 12 (1), 219-227, 2018
162018
Heat shock protein Grp78/BiP/HspA5 binds directly to TDP-43 and mitigates toxicity associated with disease pathology
L François-Moutal, DD Scott, AJ Ambrose, CJ Zerio, ...
Scientific reports 12 (1), 8140, 2022
112022
A chemical biology approach to model pontocerebellar hypoplasia type 1B (PCH1B)
L François-Moutal, S Jahanbakhsh, ADL Nelson, D Ray, DD Scott, ...
ACS chemical biology 13 (10), 3000-3010, 2018
112018
Direct targeting of TDP-43, from small molecules to biologics: the therapeutic landscape
L Francois-Moutal, DD Scott, M Khanna
RSC Chemical Biology 2 (4), 1158-1166, 2021
102021
1H, 15N and 13C backbone assignment of apo TDP-43 RNA recognition motifs
DD Scott, L Francois-Moutal, VK Kumirov, M Khanna
Biomolecular NMR assignments 13, 163-167, 2019
62019
Corrigendum: Structural Insights Into TDP-43 and Effects of Post-translational Modifications
L François-Moutal, S Perez-Miller, DD Scott, VG Miranda, N Mollasalehi, ...
Frontiers in molecular neuroscience 13, 45-45, 2020
22020
Molecular Dynamics simulation of TDP-43 RRM in the presence and absence of RNA
DD Scott, D Mowrey, K Nagarajan, L François-Moutal, A Nair, M Khanna
bioRxiv, 2022.03. 15.484514, 2022
12022
Small molecule inhibitors of tdp-43 activity and uses thereof
M Khanna, V Gokhale, L Francois-Moutal, D Scott, H Williams, J Tello, ...
US Patent App. 18/015,775, 2023
2023
Structure-Based Targeting of Tdp-43 to Further the Development of Novel Therapeutics for Neurodegenerative Diseases
DD Scott
The University of Arizona, 2022
2022
Heat Shock Protein Grp78/BiP/HspA5 Binds Directly to TDP-43 and Mitigates Toxicity Associated with Neurodegenerative Disease Pathology
L François-Moutal, D Scott, A Ambrose, C Zerio, K Dissanayake, D May, ...
2021
Structural Insights Into TDP-43 and Effects of Post-translational Modifications (vol 12, 301, 2019)
L Francois-Moutal, S Perez-Miller, DD Scott, VG Miranda, N Mollasalehi, ...
FRONTIERS IN MOLECULAR NEUROSCIENCE 13, 2020
2020
The system can't perform the operation now. Try again later.
Articles 1–16